Esler M - Search Results

1

Antihypertensives for combating dementia? A perspective on candidate molecular mechanisms and population-based prevention.

Valenzuela M, Esler M, Ritchie K, Brodaty H. Valenzuela M, et al. Among authors: esler m. Transl Psychiatry. 2012 Apr 24;2(4):e107. doi: 10.1038/tp.2012.28. Transl Psychiatry. 2012. PMID: 22832907 Free PMC article. Review.

2

Recent advances in the treatment of hypertension.

Hering D, Esler MD, Krum H, Mahfoud F, Böhm M, Sobotka PA, Schlaich MP. Hering D, et al. Among authors: esler md. Expert Rev Cardiovasc Ther. 2011 Jun;9(6):729-44. doi: 10.1586/erc.11.71. Expert Rev Cardiovasc Ther. 2011. PMID: 21714604 Review.

3

SPRINT, or False Start, Toward a Lower Universal Treated Blood Pressure Target in Hypertension.

Esler M. Esler M. Hypertension. 2016 Feb;67(2):266-7. doi: 10.1161/HYPERTENSIONAHA.115.06735. Epub 2015 Nov 9. Hypertension. 2016. PMID: 26553232 Review. No abstract available.

4

Evidence for a role for the cardiovascular amplifiers in human primary hypertension.

Jennings G, Korner PI, Sudhir K, Esler M, Angus JA, Laufer E. Jennings G, et al. Among authors: esler m. Clin Exp Pharmacol Physiol. 1991 Jan;18(1):37-41. doi: 10.1111/j.1440-1681.1991.tb01374.x. Clin Exp Pharmacol Physiol. 1991. PMID: 2032389

5

New therapeutic approaches to resistant hypertension.

Schlaich MP, Krum H, Esler MD. Schlaich MP, et al. Curr Hypertens Rep. 2010 Aug;12(4):296-302. doi: 10.1007/s11906-010-0119-1. Curr Hypertens Rep. 2010. PMID: 20509010 Review.

6

Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial.

Symplicity HTN-2 Investigators; Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Böhm M. Symplicity HTN-2 Investigators, et al. Among authors: esler md. Lancet. 2010 Dec 4;376(9756):1903-9. doi: 10.1016/S0140-6736(10)62039-9. Epub 2010 Nov 17. Lancet. 2010. PMID: 21093036 Clinical Trial.

7

Renal denervation and hypertension.

Schlaich MP, Krum H, Sobotka PA, Esler MD. Schlaich MP, et al. Am J Hypertens. 2011 Jun;24(6):635-42. doi: 10.1038/ajh.2011.35. Epub 2011 Mar 10. Am J Hypertens. 2011. PMID: 21394087 Free article. Review.

8

Renal denervation in human hypertension: mechanisms, current findings, and future prospects.

Schlaich MP, Hering D, Sobotka PA, Krum H, Esler MD. Schlaich MP, et al. Curr Hypertens Rep. 2012 Jun;14(3):247-53. doi: 10.1007/s11906-012-0264-9. Curr Hypertens Rep. 2012. PMID: 22457244 Review.

9

Effects of renal denervation on insulin resistance.

Hering D, Esler MD, Schlaich MP. Hering D, et al. Expert Rev Cardiovasc Ther. 2012 Nov;10(11):1381-6. doi: 10.1586/erc.12.140. Expert Rev Cardiovasc Ther. 2012. PMID: 23244359 Review.

10

Renal nerve ablation reduces augmentation index in patients with resistant hypertension.

Hering D, Lambert EA, Marusic P, Ika-Sari C, Walton AS, Krum H, Sobotka PA, Mahfoud F, Böhm M, Lambert GW, Esler MD, Schlaich MP. Hering D, et al. Among authors: esler md. J Hypertens. 2013 Sep;31(9):1893-900. doi: 10.1097/HJH.0b013e3283622e58. J Hypertens. 2013. PMID: 23697964 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

530 results

Search Page

Filters